BETHESDA, Md., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will host a conference call on Tuesday, November 17th, at 9:00 AM ET, to provide the formal comments from its Annual Meeting of Shareholders.
